Storys zum Thema Medizin, Gesundheit
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
LTS Lohmann Therapie-Systeme AG
LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches
mehrCES award-winning e-exoskeleton specialist German Bionic presents the Apogee+ power suit for the health sector, in Las Vegas
Berlin (ots) - Recognized with this year’sCES “Best of Innovation” Award in the Wearable Technologies category, Berlin-based robotics and wearable tech specialist German Bionic is back in Las Vegas in 2024 with its latest e-exoskeleton, the Apogee+ power suit. The device is specifically developed to provide ...
mehrNew Source of Stem Cells in Injury-Affected Brains of Patients
mehrResearch Institute for Sustainability (RIFS)
New EU research project: A Network for Healthier Cities (Net4Cities)
Press release Horizon Europe Grant A Network for Healthier Cities The transport sector is a major contributor to environmental degradation, including air and noise pollution, damage to ecosystems and human health. To monitor air and noise pollution and generate data that will aid in assessing their health impacts related to it, the ...
mehrLTS Lohmann Therapie-Systeme AG
LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches
mehr
Fraunhofer-Institut für Produktionstechnologie IPT
Pooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systems
mehrPress release: STADA strikes partnership with CR Sanjiu in China to drive growth of its cough and cold portfolio
Ein DokumentmehrTakeda Pharma Vertrieb GmbH & Co. KG
The European Commission Approves Label Update for TAKHZYRO® (lanadelumab), Expanding Its Use to a Broader Group of Paediatric Patients with Recurrent Attacks of Hereditary Angioedema (HAE)
Zurich (ots/PRNewswire) - - TAKHZYRO® is the First Routine Prevention Treatment of HAE Approved in the EU for Patients Under the Age of Six. - The therapeutical indication for TAKHZYRO® has been extended to patients aged 2 years and older.1 - Offers a New Preventative Treatment Option for young HAE patients with ...
mehrBehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
NASHVILLE, Tenn., Aachen, Germany (ots) - The merger will accelerate a new digitally-powered care management solution for chronic pain and beyond; Pharmaceutical company Grünenthal becomes the largest investor in the combined enterprise BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern ...
mehrBehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
NASHVILLE, Tenn., Aachen, Germany (ots) - The merger will accelerate a new digitally-powered care management solution for chronic pain and beyond; Pharmaceutical company Grünenthal becomes the largest investor in the combined enterprise BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern ...
mehrSHL Medical achieves EcoVadis® Silver Medal and sets ambitious science-based climate targets
mehr
Ten benefits of a daily intake of citrus fruits during winter season
mehrBiomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
mehrUnderstanding the Role of GIP in Managing Diabetes and Obesity
The increasing amount of patients with obesity and type 2 diabetes benefit greatly from the recently developed GIPR:GLP-1R co-agonists. These novel compounds lead to substantial weight loss, offering a revolutionary approach to patients worldwide. Although the hormone glucose-dependent insulinotropic polypeptide (GIP) was already shown by Helmholtz Munich scientists to decrease body weight via the brain GIP receptor, the ...
mehrTechnische Universität München
Start-up dedicated to developing new antibiotics
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Smartbax nominated for Falling Walls award Start-up dedicated to developing new antibiotics • New approach against resistant pathogens • Agent damages protein transport and energy balance of bacteria • Two TUM spin-offs nominated for Science Breakthrough of the Year at Falling Walls Summit It all began with basic research: While conducting laboratory experiments, a team ...
mehr- 2
PIONEER+ becomes Big Data Platform for Prostate Cancer of the EAU's UroEvidenceHub
mehr - 5
Reflecting on a successful Pharma Forum 2023
Ein Dokumentmehr
The easiest fruit celebrates its 'Apple Day'
mehrGerresheimer awarded EcoVadis Gold status again
Duesseldorf (ots) - - Gerresheimer among the top 5% of assessed businesses - Total score increases to 72/100 points - Status demonstrates consistent implementation of CSR strategy Gerresheimer, an innovative provider of systems and solutions and a global partner for the pharma, biotech, and cosmetic industries, has once again been awarded Gold status by the ratings agency EcoVadis. EcoVadis assesses the performance of ...
mehrSHL Medical and Lifecore Biomedical enter co-marketing partnership agreement
mehrWorld Health Summit kicks off in Berlin / Experts from around the world meet at the most important forum on global health
Berlin (ots) - The World Health Summit 2023, the world's leading meeting for global health, began Sunday morning in Berlin. From October 15 to 17, international representatives from politics, science, business and civil society will discuss crucial issues in global health under the motto "A Defining Year for Global ...
mehr- 3
EU Provides 1 Mio. to Researchers to Advance Personalised Oncology
Ein Dokumentmehr canSERV Releases Open Call for Transnational Service Provision
Ein Dokumentmehr
Interpreting Large-Scale Medical Datasets: ScPoli Enables Multi-Scale Representations of Cells and Samples
The increasing amount of data recorded in medical research can only lead to scientific breakthroughs and essential therapies for patients if interpreted and analyzed correctly. Computer scientists at Helmholtz Munich developed a generative model named scPoli (single-cell population level integration), that performs ...
mehr- 6
"SUITX by Ottobock" sets new standards in exoskeleton technology
mehr Hearing Loss Company Acousia Therapeutics Green Lighted for Game-Changing Phase 2 Trial
Tübingen, Germany (ots/PRNewswire) - Acousia Therapeutics, a pioneer clinical-stage biotech company focused on the development of novel drug therapies for the prevention and treatment of acute and chronic forms of hearing loss, received approval from the German regulatory authorities (BfArM) for its groundbreaking Phase 2 clinical trial of the etiology-agnostic ...
mehrHearing Loss Company Acousia Therapeutics Green Lighted for Game-Changing Phase 2 Trial
Tübingen, Germany (ots) - Acousia Therapeutics, a pioneer clinical-stage biotech company focused on the development of novel drug therapies for the prevention and treatment of acute and chronic forms of hearing loss, received approval from the German regulatory authorities (BfArM) for its groundbreaking Phase 2 clinical trial of the etiology-agnostic otoprotectant ...
mehrTechnische Universität München
Minimizing antibiotics usage: “The key starting point is animal health”
TECHNICAL UNIVERSITY OF MUNICH PRESS RELEASE Interview with Prof. Julia Steinhoff-Wagner on antibiotic resistance “The key starting point is animal health” - New research project at TUM addresses the minimization of antibiotics in poultry farming - Healthy animals are the most important precondition for reducing the administration of antibiotics - Transfer of ...
mehrCritical Messaging Association (CMA)
#CMABerlin23: Safe professional communication requires several independent infrastructures
Berlin (ots) - The Critical Messaging Association (CMA) invited experts from all over the world to the international congress #CMABerlin23 (September 26 to 29, 2023) in Berlin. CMA members, security communications executives, and guests from science and industry from Europe and North America discussed communication solutionsthat function reliably even in critical ...
mehr